157 related articles for article (PubMed ID: 280705)
1. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
McCoy JL; Jerome LF; Anderson C; Cannon GB; Alford TC; Connor RJ; Oldham RK; Herberman RB
J Natl Cancer Inst; 1976 Nov; 57(5):1045-9. PubMed ID: 1003541
[TBL] [Abstract][Full Text] [Related]
3. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
4. Inhibition of leukocyte migration by human breast-cancer-associated antigens.
Kadish AS; Marcus DM; Bloom BR
Int J Cancer; 1976 Nov; 18(5):581-6. PubMed ID: 62721
[TBL] [Abstract][Full Text] [Related]
5. Cellular antitumor immune response in women with risk factors for breast cancer.
Sanner T; Brennhovd I; Christensen I; Jørgensen O; Kvaløy S
Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH
J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
10. Use of the leukocyte migration inhibition assay to evaluate antigenic differences in human breast cancers and melanomas.
Cannon B; McCoy JL; Connor RJ; Jerome L; Keys L; Dean HH; Herberman RB
J Natl Cancer Inst; 1978 May; 60(5):969-78. PubMed ID: 76682
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
[No Abstract] [Full Text] [Related]
13. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cellular immune response to cancer of the breast.
Herberman RB
Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
[TBL] [Abstract][Full Text] [Related]
16. Humoral immunologic response in patients with tumors of the breast.
Glazman H; Salwa J; Harlozińska A
Arch Immunol Ther Exp (Warsz); 1973; 21(1):175-84. PubMed ID: 4720430
[No Abstract] [Full Text] [Related]
17. Sensitization to tumour-associated antigens in human breast carcinoma.
Cochran AJ; Grant RM; Spilg WG; Mackie RM; Ross CE; Hoyle DE; Russell JM
Int J Cancer; 1974 Jul; 14(1):19-25. PubMed ID: 4617707
[No Abstract] [Full Text] [Related]
18. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
[No Abstract] [Full Text] [Related]
19. The leukocyte migration inhibition response to certain breast cancer-related antigens (MCF-7 and MuMTV): their potential as discriminants.
Wanebo HJ; Fukuda M; Tsuei L; Sarkar N; Ashikari H
Surgery; 1979 Aug; 86(2):275-83. PubMed ID: 462374
[TBL] [Abstract][Full Text] [Related]
20. Immunology: breast cancer.
Heppner GH
Recent Results Cancer Res; 1976; (57):95-108. PubMed ID: 189376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
